Suppr超能文献

大麻素配体、受体与酶:药理学工具及治疗潜力

Cannabinoid ligands, receptors and enzymes: Pharmacological tools and therapeutic potential.

作者信息

Hourani Wafa, Alexander Stephen P H

机构信息

School of Life Sciences, Medical School, University of Nottingham, Nottingham, UK.

出版信息

Brain Neurosci Adv. 2018 Jun 19;2:2398212818783908. doi: 10.1177/2398212818783908. eCollection 2018 Jan-Dec.

Abstract

Endocannabinoids have been identified to have roles in numerous physiological and pathological processes. Largely due to the association of the effects of administration on mental states, the CNS impact of the endocannabinoid system has been the most intensively studied. Here, we provide a brief summary of the endocannabinoid system, comprising the receptors and the multiple endogenous lipid derivatives which activate them, as well as the enzymes which control the levels of these lipid derivatives. We identify pharmacological tools which may be used to interrogate the endocannabinoid system, as well as current and future options to exploit the system in the clinic.

摘要

内源性大麻素已被证实参与众多生理和病理过程。很大程度上由于其给药对精神状态的影响,内源性大麻素系统对中枢神经系统的影响得到了最为深入的研究。在此,我们对内源性大麻素系统进行简要概述,该系统包括受体、激活这些受体的多种内源性脂质衍生物,以及控制这些脂质衍生物水平的酶。我们还确定了可用于研究内源性大麻素系统的药理学工具,以及目前和未来在临床上利用该系统的选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a308/7058259/bc1bcb4f421f/10.1177_2398212818783908-fig1.jpg

相似文献

1
Cannabinoid ligands, receptors and enzymes: Pharmacological tools and therapeutic potential.
Brain Neurosci Adv. 2018 Jun 19;2:2398212818783908. doi: 10.1177/2398212818783908. eCollection 2018 Jan-Dec.
2
The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.
CNS Neurol Disord Drug Targets. 2017;16(4):370-379. doi: 10.2174/1871527316666170223161908.
3
The endocannabinoid system: physiology and pharmacology.
Alcohol Alcohol. 2005 Jan-Feb;40(1):2-14. doi: 10.1093/alcalc/agh110. Epub 2004 Nov 18.
5
Role of lipids and lipid signaling in the development of cannabinoid tolerance.
Life Sci. 2005 Aug 19;77(14):1543-58. doi: 10.1016/j.lfs.2005.05.005.
6
From endocannabinoid profiling to 'endocannabinoid therapeutics'.
Curr Opin Chem Biol. 2009 Jun;13(3):321-31. doi: 10.1016/j.cbpa.2009.04.615. Epub 2009 Jun 3.
8
[Endogenous cannabinoid receptor ligands--anandamide and 2-arachidonoylglycerol].
Yakugaku Zasshi. 2006 Feb;126(2):67-81. doi: 10.1248/yakushi.126.67.
10
Therapeutic potential of cannabinoids in schizophrenia.
Recent Pat CNS Drug Discov. 2014 Apr;9(1):13-25. doi: 10.2174/1574889809666140307115532.

引用本文的文献

1
Phytocanabinoids and synthetic cannabinoids: from recreational consumption to potential therapeutic use - a review.
Front Toxicol. 2025 Jan 28;6:1495547. doi: 10.3389/ftox.2024.1495547. eCollection 2024.
2
The Anticancer Activity of Cannabinol (CBN) and Cannabigerol (CBG) on Acute Myeloid Leukemia Cells.
Molecules. 2024 Dec 18;29(24):5970. doi: 10.3390/molecules29245970.
4
Cannabinoids and the Gastrointestinal Tract.
Clin Gastroenterol Hepatol. 2023 Dec;21(13):3217-3229. doi: 10.1016/j.cgh.2023.07.031. Epub 2023 Sep 9.
5
Measuring white matter microstructure in 1,457 cannabis users and 1,441 controls: A systematic review of diffusion-weighted MRI studies.
Front Neuroimaging. 2023 Mar 7;2:1129587. doi: 10.3389/fnimg.2023.1129587. eCollection 2023.
7
The Impact of Early Life Exposure to Cannabis: The Role of the Endocannabinoid System.
Int J Mol Sci. 2021 Aug 9;22(16):8576. doi: 10.3390/ijms22168576.
8
Cannabinoids as Key Regulators of Inflammasome Signaling: A Current Perspective.
Front Immunol. 2021 Jan 28;11:613613. doi: 10.3389/fimmu.2020.613613. eCollection 2020.
9
Effects of Cannabinoid Agonists and Antagonists on Sleep in Laboratory Animals.
Adv Exp Med Biol. 2021;1297:97-109. doi: 10.1007/978-3-030-61663-2_7.

本文引用的文献

1
Rationale for cannabis-based interventions in the opioid overdose crisis.
Harm Reduct J. 2017 Aug 18;14(1):58. doi: 10.1186/s12954-017-0183-9.
2
Cannabinoids in treatment-resistant epilepsy: A review.
Epilepsy Behav. 2017 May;70(Pt B):341-348. doi: 10.1016/j.yebeh.2016.11.012. Epub 2017 Feb 8.
3
Thermolytic Degradation of Synthetic Cannabinoids: Chemical Exposures and Pharmacological Consequences.
J Pharmacol Exp Ther. 2017 Apr;361(1):162-171. doi: 10.1124/jpet.116.238717. Epub 2017 Jan 13.
4
"Zombie" Outbreak Caused by the Synthetic Cannabinoid AMB-FUBINACA in New York.
N Engl J Med. 2017 Jan 19;376(3):235-242. doi: 10.1056/NEJMoa1610300. Epub 2016 Dec 14.
5
Cannabimimetic phytochemicals in the diet - an evolutionary link to food selection and metabolic stress adaptation?
Br J Pharmacol. 2017 Jun;174(11):1464-1483. doi: 10.1111/bph.13676. Epub 2017 Jan 16.
6
High-resolution crystal structure of the human CB1 cannabinoid receptor.
Nature. 2016 Dec 22;540(7634):602-606. doi: 10.1038/nature20613. Epub 2016 Nov 16.
7
Crystal Structure of the Human Cannabinoid Receptor CB.
Cell. 2016 Oct 20;167(3):750-762.e14. doi: 10.1016/j.cell.2016.10.004.
8
The Endocannabinoid System as a Therapeutic Target in Glaucoma.
Neural Plast. 2016;2016:9364091. doi: 10.1155/2016/9364091. Epub 2016 Jan 12.
9
Allosteric Modulators: A Side Door.
J Med Chem. 2016 Jan 14;59(1):42-3. doi: 10.1021/acs.jmedchem.5b01824. Epub 2015 Dec 8.
10
Therapeutic potential of cannabis-related drugs.
Prog Neuropsychopharmacol Biol Psychiatry. 2016 Jan 4;64:157-66. doi: 10.1016/j.pnpbp.2015.07.001. Epub 2015 Jul 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验